A Dual‐Threshold Strategy Enables Reliable Biopsy‐Free Diagnosis of High‐Risk Prostate Cancer
A dual-threshold non-invasive strategy is established for predicting HRPCa in biopsy-free radical prostatectomy candidates pre-screened by the USTC model, while its applicability to unscreened or low to intermediate-risk populations remains unproven.
Authors
- Yong Liang (ORCID: https://orcid.org/0000-0001-5643-8966)
- Zihao Zhang (ORCID: https://orcid.org/0000-0001-9286-8189)
- Cheng Chen (ORCID: https://orcid.org/0000-0002-0586-0646)
- Yachao Liu
- Zhangcheng Liao
- Zhiyao Xu
- Z H Chen
- Shaoxi Niu
- Hui Xie
- Yifan Ma
- Tao Tao
Institutions
- Wannan Medical College (CN)
- University of Science and Technology of China (CN)
- Central South University (CN)
- Bengbu Medical College (CN)
- Chinese PLA General Hospital (CN)
- Anhui Provincial Hospital (CN)
- Xijing Hospital (CN)
- Xiangya Hospital Central South University (CN)
- Air Force Medical University (CN)
Publication Details
- Journal
- The Prostate
- Published
- 2026-02-23
- DOI
- https://doi.org/10.1002/pros.70145
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00